Marcus Remmers
Direttore/Membro del Consiglio presso Invetx, Inc.
Profilo
Marcus Remmers is currently working as a Director at Invetx, Inc. and as a Partner at Novo Holdings AS (Denmark).
He has an undergraduate degree from the University of Freiburg and another undergraduate degree from the University of Münster.
Posizioni attive di Marcus Remmers
Società | Posizione | Inizio |
---|---|---|
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Corporate Officer/Principal | - |
Invetx, Inc.
Invetx, Inc. Medical SpecialtiesHealth Technology Invetx, Inc. operates as a veterinary therapeutics company. It focuses on biopharmaceuticals that bring human biotechnology to animal health. The company is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 26/06/2023 |
Formazione di Marcus Remmers
University of Münster | Undergraduate Degree |
University of Freiburg | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Finance |
Invetx, Inc.
Invetx, Inc. Medical SpecialtiesHealth Technology Invetx, Inc. operates as a veterinary therapeutics company. It focuses on biopharmaceuticals that bring human biotechnology to animal health. The company is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Marcus Remmers